BriaCell Therapeutics (FRA:8BT) Days Payable: (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8BT BriaCell Therapeutics Corp FRA:8BT
38 GF Score
Price €3.54
! 2 Warning Signs
View Full Analysis

What is BriaCell Therapeutics Days Payable?

BriaCell Therapeutics's average Accounts Payable for the three months ended in Apr. 2026 was €0.00 Mil. BriaCell Therapeutics's Cost of Goods Sold for the three months ended in Apr. 2026 was €0.03 Mil. Hence, BriaCell Therapeutics's Days Payable for the three months ended in Apr. 2026 was 0.00.

The historical rank and industry rank for BriaCell Therapeutics's Days Payable or its related term are showing as below:

FRA:8BT's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 111.24
* Ranked among companies with meaningful Days Payable only.

BriaCell Therapeutics's Days Payable stayed the same from Apr. 2025 () to Apr. 2026 (). stayed the same

BriaCell Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for BriaCell Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BriaCell Therapeutics Days Payable Chart

BriaCell Therapeutics Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31,127.90 17,782.45

BriaCell Therapeutics Quarterly Data
Jan21 Apr21 Oct21 Jan22 Apr22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,288.97 11,460.85

FRA:8BT vs VRTX, REGN, MRNA: Days Payable Comparison

For the Biotechnology subindustry, BriaCell Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BriaCell Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Days Payable falls into.


FRA:8BT
38GF Score
BriaCell Therapeutics Corp FRA:8BT
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BriaCell Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BriaCell Therapeutics's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as

Days Payable (A: Jul. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jul. 2024 ) + Accounts Payable (A: Jul. 2025 )) / count ) / Cost of Goods Sold (A: Jul. 2025 )*Days in Period
=( (6.6267267350522 + 2.8689904329212) / 2 ) / 0.097*365
=4.7478585839867 / 0.097*365
=17,865.65

BriaCell Therapeutics's Days Payable for the quarter that ended in Apr. 2026 is calculated as:

Days Payable (Q: Apr. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jan. 2026 ) + Accounts Payable (Q: Apr. 2026 )) / count ) / Cost of Goods Sold (Q: Apr. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0.028*365 / 4
=0 / 0.028*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BriaCell Therapeutics Business Description

Other Exchanges BCTX:USABCT:Canada
Address 235-15th Street, Suite 300, 3rd Floor, Bellevue Centre, West Vancouver, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
38GF Score

Get the complete analysis for FRA:8BT

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.54
Price